Resultats globals: 83 registres trobats en 0.14 segons.
Articles, 54 registres trobats
Documents de recerca, 29 registres trobats
Articles 54 registres trobats  1 - 10següentfinal  anar al registre:
1.
1 p, 185.6 KB Use of anticoagulation in patients with breast cancer and atrial fibrillation / Sorigue, Marc (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
2019 - 10.1016/j.breast.2019.07.005
Breast, Vol. 48 (december 2019) , p. 98  
2.
9 p, 2.0 MB Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel / Pasculli, B. (Fondazione IRCCS Casa Sollievo della Sofferenza Laboratorio di Oncologia) ; Barbano, R. (Fondazione IRCCS Casa Sollievo della Sofferenza Laboratorio di Oncologia) ; Rendina, M. (Fondazione IRCCS Casa Sollievo della Sofferenza Laboratorio di Oncologia) ; Fontana, A. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Biostatistica) ; Copetti, M. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Biostatistica) ; Mazza, T. (Fondazione IRCCS Casa Sollievo della Sofferenza. Bioinformatics Unit) ; Valori, V.M. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Oncologia) ; Morritti, M. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Oncologia) ; Maiello, E. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Oncologia) ; Graziano, P. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Anatomia Patologica) ; Murgo, R. (Fondazione IRCCS Casa Sollievo della Sofferenza. UO di Chirurgia Senologica) ; Fazio, V.M. (Fondazione IRCCS Casa Sollievo della Sofferenza Laboratorio di Oncologia) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Parrella, P. (Fondazione IRCCS Casa Sollievo della Sofferenza Laboratorio di Oncologia) ; Universitat Autònoma de Barcelona
MicroRNA-210-3p is the most prominent hypoxia regulated microRNA, and it has been found significantly overexpressed in different human cancers. We performed the expression analysis of miR-210-3p in a retrospective cohort of breast cancer patients with a median follow-up of 76 months (n = 283). [...]
2019 - 10.1038/s41598-019-51581-3
Scientific reports (Nature Publishing Group), Vol. 9 Núm. 1 (january 2019) , p. 14913  
3.
16 p, 2.3 MB Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer / Palomeras, S. (Universitat de Girona. Departament de Ciències Mèdiques) ; Diaz-Lagares, Á. (University Clinical Hospital of Santiago(CHUS/SERGAS)) ; Viñas, G. (Girona Biomedical Research Institute (IDIBGI)) ; Setien, F. (Hospital Universitari de Bellvitge) ; Ferreira, H.J. (Hospital Universitari de Bellvitge) ; Oliveras, G. (Pathology Department. Dr. Josep Trueta Hospital and Catalan Institute of Health (ICS)) ; Crujeiras, A.B. (CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn)) ; Hernández, A. (Institut Català d'Oncologia) ; Lum, D.H. (University of Utah. Huntsman Cancer Institute) ; Welm, A.L. (University of Utah. Huntsman Cancer Institute) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Puig, T. (Universitat de Girona. Departament de Ciències Mèdiques) ; Universitat Autònoma de Barcelona
Background: Acquired resistance to trastuzumab is a major clinical problem in the treatment of HER2-positive (HER2+) breast cancer patients. The selection of trastuzumab-resistant patients is a great challenge of precision oncology. [...]
2019 - 10.1186/s13058-019-1160-x
Breast cancer research, Vol. 21 Núm. 1 (may 2019) , p. 79  
4.
13 p, 2.2 MB Epigenetic regulation of gfi1 in endocrine-related cancers : A role regulating tumor growth / Ashour, N. (Departamento de Biología de Sistemas. Unidad Docente de Bioquímica y Biología Molecular. Universidad de Alcalá) ; Angulo, J.C. (Servicio de Urología. Hospital Universitario de Getafe. Fundación para la Investigación Biomédica del Hospital Universitario de Getafe. Universidad Europea de Madrid) ; González-Corpas, A. (Departamento de Biología de Sistemas. Unidad Docente de Bioquímica y Biología Molecular. Universidad de Alcalá) ; Orea, M.J. (Departamento de Biología de Sistemas. Unidad Docente de Bioquímica y Biología Molecular. Universidad de Alcalá) ; Lobo, M.V.T. (Departamento de Biomedicina y Biotecnología. Universidad de Alcalá. Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS)) ; Colomer, R. (Department of Medicine. Universidad Autónoma de Madrid) ; Colás, B. (Departamento de Biología de Sistemas. Unidad Docente de Bioquímica y Biología Molecular. Universidad de Alcalá) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ropero, S. (Departamento de Biología de Sistemas. Unidad Docente de Bioquímica y Biología Molecular. Universidad de Alcalá) ; Universitat Autònoma de Barcelona
Prostate and breast cancer constitute the most common cancers among men and women worldwide. The aging population is one of the main risk factors for prostate and breast cancer development and accumulating studies link aging with epigenetic changes. [...]
2020 - 10.3390/ijms21134687
International journal of molecular sciences, Vol. 21 Núm. 13 (july 2020) , p. 1-12  
5.
14 p, 892.1 KB Discovery of novel DNA methylation biomarkers for non-invasive sporadic breast cancer detection in the Latino population / Cappetta, M. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Fernandez, L. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Brignoni, L. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Artagaveytia, N. (Departamento Básico de Medicina. Facultad de Medicina. Universidad de la República) ; Bonilla, C. (Population Health Sciences. Bristol Medical School. University of Bristol) ; López, Miguel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bertoni, B. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Berdasco, Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Human diversity is one of the main pitfalls in the development of robust worldwide biomarkers in oncology. Epigenetic variability across human populations is associated with different genetic backgrounds, as well as variable lifestyles and environmental exposures, each of which should be investigated. [...]
2021 - 10.1002/1878-0261.12842
Molecular Oncology, Vol. 15 Núm. 2 (february 2021) , p. 473-486  
6.
14 p, 1.4 MB Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors / Pasculli, B. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Barbano, R. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Fontana, A. (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Biagini, T. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratory of Bioinformatics Unit) ; Di Viesti, M.P. (Department of Medicine. Scuola Medica Salernitana," University of Salerno) ; Rendina, M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Valori, V.M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Morritti, M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Bravaccini, S. (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS. Biosciences Laboratory) ; Ravaioli, S. (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS. Biosciences Laboratory) ; Maiello, E. (Fondazione IRCCS Casa Sollievo Della Sofferenza. UO di Oncologia. San Giovanni Rotondo) ; Graziano, P. (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Murgo, R. (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Copetti, M. (Fondazione IRCCS Casa Sollievo Della Sofferenza) ; Mazza, T. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratory of Bioinformatics Unit) ; Fazio, V.M. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Parrella, P. (Fondazione IRCCS Casa Sollievo Della Sofferenza. Laboratorio di Oncologia) ; Universitat Autònoma de Barcelona
miR-155-5p is a well-known oncogenic microRNA, showing frequent overexpression in human malignancies, including breast cancer. Here, we show that high miR-155-5p levels are associated with unfavorable prognostic factors in two independent breast cancer cohorts (CSS cohort, n = 283; and TCGA-BRCA dataset, n = 1,095). [...]
2020 - 10.3389/fonc.2020.01415
Frontiers in Oncology, Vol. 10 (december 2020) , p. 1415  
7.
25 p, 4.2 MB Cx43 and Associated Cell Signaling Pathways Regulate Tunneling Nanotubes in Breast Cancer Cells / Tishchenko, Alexander (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Azorín, Daniel D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vidal-Brime, Laia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; José Muñoz, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jiménez Arenas, Pol (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pearce, Christopher (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Girao, Henrique (University of Coimbra. Faculty of Medicine) ; Ramón y Cajal, Santiago (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Aasen, Trond (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Connexin 43 (Cx43) forms gap junctions that mediate the direct intercellular diffusion of ions and small molecules between adjacent cells. Cx43 displays both pro- and anti-tumorigenic properties, but the mechanisms underlying these characteristics are not fully understood. [...]
2020 - 10.3390/cancers12102798
Cancers, Vol. 12 Núm. 10 (2020) , p. 2798  
8.
33 p, 1.1 MB Engineering a nanostructured nucleolin-binding peptide for intracellular drug delivery in triple-negative breast cancer stem cells / Pesarrodona Roches, Mireia (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Sánchez-García, Laura (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Seras-Franzoso, Joaquín (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sánchez Chardi, Alejandro (Universitat Autònoma de Barcelona. Servei de Microscòpia) ; Baltá-Foix, Ricardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Cámara-Sánchez, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gener, Petra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jara, José Juan (CIBER de Bioingeniería, Biomateriales y Nanomedicina) ; Pulido, Daniel (CIBER de Bioingeniería, Biomateriales y Nanomedicina) ; Serna, Naroa (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Schwartz, Simó (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Royo, Miriam (CIBER de Bioingeniería, Biomateriales y Nanomedicina) ; Villaverde Corrales, Antonio (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Abasolo, Ibane (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vázquez Gómez, Esther (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia
Five peptide ligands of four different cell surface receptors (nucleolin, CXCR1, CMKLR1, and CD44v6) have been evaluated as targeting moieties for triple-negative human breast cancers. Among them, the peptide F3, derived from phage display, promotes the fast and efficient internalization of a genetically fused green fluorescent protein (GFP) inside MDA-MB-231 cancer stem cells in a specific receptor-dependent fashion. [...]
2020 - 10.1021/acsami.9b15803
ACS applied materials & interfaces, Vol. 12, Issue 5 (February 2020) , p. 5381-5388
2 documents
9.
8 p, 256.7 KB Effect of protocol-related variables and women's characteristics on the cumulative false-positive risk in breast cancer screening / Román, R. (Institut Municipal d'Investigació Mèdica (Barcelona)) ; Sala, Maria (Institut Municipal d'Investigació Mèdica (Barcelona)) ; Salas, D. (Centre Superior d'Investigació en Salut Pública, València) ; Ascunce, N. (Instituto de Salud Pública de Navarra) ; Zubizarreta Alberdi, Raquel (Conselleria de Sanidade de la Xunta de Galicia) ; Castells, Xavier (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública)
Background: Reducing the false-positive risk in breast cancer screening is important. We examined how the screening-protocol and women's characteristics affect the cumulative false-positive risk. Methods: This is a retrospective cohort study of 1 565 364 women aged 45-69 years who underwent 4 739 498 screening mammograms from 1990 to 2006. [...]
2011 - 10.1093/annonc/mdr032
Annals of oncology, Vol. 23 (march 2011) , p. 104-111  
10.
10 p, 517.2 KB Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study) / Kogevinas, M (Institut Hospital del Mar d'Investigacions Mèdiques) ; Espinosa, Ana (CIBER Epidemiología y Salud Pública (CIBERESP)) ; Castelló, Adela (University of Alcalá) ; Gómez Acebo, Inés (Universidad de Cantabria - IDIVAL) ; Guevara, Marcela (Public Health Institute of Navarra, IdiSNA) ; Martin, Vicente (Grupo de Investigación en Interacciones Gen-Ambiente y Salud, Instituto de Biomedicina (IBIOMED), Universidad de León) ; Amiano, Pilar (Public Health Division of Gipuzkoa, BioDonostia Research Institute) ; Alguacil, Juan (Centro de Investigación en Recursos Naturales, Salud, y Medio Ambiente (RENSMA), Universidad de Huelva) ; Peiro, Rosana (Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana FISABIO - Salud Pública) ; Moreno, Victor (Universitat de Barcelona) ; Costas, Laura (Unit of Molecular Epidemiology and Genetics in Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology) ; Fernández-Tardón, Guillermo (Instituto Universitario de Oncología, Universidad de Oviedo) ; Jimenez, Jose Juan (Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Hospitales Universitarios de Granada/Universidad de Granada) ; Marcos-Gragera, Rafael (Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi)) ; Perez-Gomez, Beatriz (National Centre for Epidemiology, Carlos III Institute of Health) ; Llorca, Javier (Universidad de Cantabria - IDIVAL) ; Moreno-Iribas, Conchi (Public Health Institute of Navarra, IdiSNA) ; Fernández-Villa, Tania (Grupo de Investigación en Interacciones Gen-Ambiente y Salud, Instituto de Biomedicina (IBIOMED), Universidad de León) ; Oribe, Madalen (Public Health Division of Gipuzkoa, BioDonostia Research Institute) ; Aragones, Nuria (Epidemiology Section) ; Papantoniou, Kyriaki (Center of Public Health, Medical University of Vienna) ; Pollán, Marina (National Center of Epidemiology, Instituto de Salud Carlos III) ; Castano-Vinyals, Gemma (CIBER Epidemiología y Salud Pública (CIBERESP)) ; Romaguera, Dora (CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN)) ; Universitat Autònoma de Barcelona
Modern life involves mistimed sleeping and eating patterns that in experimental studies are associated with adverse health effects. We assessed whether timing of meals is associated with breast and prostate cancer risk taking into account lifestyle and chronotype, a characteristic correlating with preference for morning or evening activity. [...]
2018 - 10.1002/ijc.31649
International Journal of Cancer, Vol. 143 (july 2018) , p. 2380-2389  

Articles : 54 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 29 registres trobats  1 - 10següentfinal  anar al registre:
1.
39 p, 1.0 MB Estudi de cohorts: Estudi de l'amplificació 9p24 en cèl·lules tumorals de càncer de mama triple negatiu com a predictor de mala resposta a la quimioteràpia neoadjuvant / Alcoverro Godoy, Carmen ; Lerma Puertas, Enrique, dir. (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Universitat Autònoma de Barcelona. Facultat de Medicina
Antecedents: El càncer de mama triple negatiu (CMTN) correspon al 15-20% dels càncers de mama diagnosticats. Aquest subtipus tumoral s'associa a un curs clínic més agressiu, edat d'aparició més precoç, major potencial metastàtic i menors taxes de curació. [...]
Antecedentes: El cáncer de mama triple negativo (CMTN) corresponde al 15-20% de los cáncer de mama diagnosticados. Este subtipo tumoral se asocia a un curso clínico más agresivo, edad de aparición más precoz, mayor potencial metastásico y menores tasas de curación. [...]
Background: Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancers. This tumor subtype is associated with a more aggressive clinical course, earlier age of onset, higher metastatic potential and lower cure rates. [...]

2020
Grau de Medicina [1192]  
2.
1 p, 1.0 MB Exosomes as nanocarriers for anti-miR-21 in Triple Negative Breast Cancer / Rondón Cebrian, Marta ; Martí Ripoll, Mercè, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
Triple Negative Breast Cancer (TNBC) is characterized by not expressing estrogen, progesterone nor HER2 receptors and is considered to be the breast cancer subtype with the worst prognostic. Nowadays, TNBC's treatments have been a challenge due to the lack of targeted therapies and its heterogeneity. [...]
2020
Grau en Biotecnologia [815]  
3.
1 p, 1.4 MB Design and engineering of trastuzumab emtansine production plant : part III, upstream, bioreactions and fermentation of the antitumorigenic agent Ansamitocin P3 / Puig Laborda, Víctor ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Grau en Biotecnologia [815]  
4.
1 p, 2.3 MB Design and engineering of trastuzumab emtansine production plant : part I, introduction to T-DM1 production process and upstream of monoclonal antibody trastuzumab / Salse Guiu, Laura ; Universitat Autònoma de Barcelona. Facultat de Biociències
2018
Grau en Biotecnologia [815]  
5.
29 p, 724.4 KB Correlation Between Ultrasonography and Magnetic Resonance Imaging with Pathology-Measured Tumor Size in Women with Recently Diagnosed Breast Cancer. Optimizing tumor-size estimation with imaging techniques for higher precision / Brenner Anidjar, Rony-David ; Luna Tomás, Miguel-Ángel, dir. ; Universitat Autònoma de Barcelona. Facultat de Medicina
The use of Breast-MRI in surgical planning of breast cancer is a field of controversy due to its high sensitivity but low specificity, alongside with overestimation of tumor-size. It has been proven many factors contribute to this overestimation. [...]
El uso de Resonancia Magnética Mamaria (RMM) en la planificación pre-quirúrgica del cáncer de mama es controvertido dada la alta sensibilidad y baja especificidad, junto con la sobreestimación del tamaño tumoral. [...]

2017
Grau de Medicina [1192]  
6.
1 p, 942.9 KB The role of ALDHbr BCSCs as prognostic markers and therapeutic targets in breast cancer / Grima Reyes, Manuel ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2016
Grau en Bioquímica [814]  
7.
1 p, 17.8 MB Proteomics application in breast cancer / Blanco Vega, Noemí ; Bassols Teixidó, Anna Maria, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
8.
1 p, 2.5 MB Anticancer prodrugs, the new way of using nanoparticles / Jiménez Giménez, Esther ; Farrés i Vicén, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
9.
1 p, 5.4 MB MicroRNAs' role in epithelial-mesenchymal transition in breast cancer / Delowar Akther, Hossain ; Itarte, Emilio, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  
10.
1 p, 1.0 MB Breast cancer stem cells generated through the epithelial mesenchymal transition / Ibars Sillés, Patricia ; Itarte, Emilio, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Bioquímica [814]  

Documents de recerca : 29 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.